Castle Rock Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
PCA
Castle Rock Wealth Management's LLY Position: Q3 2026 in Review
Castle Rock Wealth Management reduced its Eli Lilly (LLY) stake by 33% in Q3 2026, selling an estimated $1.06M and leaving 1,863 shares worth $2.16M. The position accounts for 0.41% of the portfolio, ranked #61.
Castle Rock Wealth Management first reported a position in LLY in Q4 2022 and has held it in 16 quarters since. The position peaked at $3.29M in Q2 2026. 646 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Castle Rock Wealth Management held 1,863 shares of Eli Lilly worth $2.16M as of Q3 2026.
- Castle Rock Wealth Management sold 900 Eli Lilly shares in Q3 2026, an estimated $1.06M.
- Eli Lilly made up 0.41% of Castle Rock Wealth Management's portfolio in Q3 2026, its #61 holding.
- Castle Rock Wealth Management first reported a position in Eli Lilly in Q4 2022 and has held it in 16 quarters since.
- Castle Rock Wealth Management's Eli Lilly position peaked at $3.29M in Q2 2026.
- 646 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Castle Rock Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.